Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP) Institutional Ownership

CUSIP: 890260854

13F Institutional Holders and Ownership History from Q2 2023 to Q3 2024

Type / Class
Equity / Common Stock
Symbol
TNXP on Nasdaq
Shares outstanding
186,616,143
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 890260854?
CUSIP 890260854 identifies TNXP - Tonix Pharmaceuticals Holding Corp. - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Significant Owners of Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SABBY MANAGEMENT, LLC 0.7% $143,694 1,306,313 SABBY MANAGEMENT, LLC 31 Dec 2024

Institutional Holders of Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q3 0 $0 -$19,636 0
2024 Q2 28,155 $19,636 -$2,066,231 $0.85 2
2024 Q1 13,393 $2,493 -$220,889 $1.00 5
2023 Q4 14,436,164 $5,809,652 +$3,945,317 $0.40 34
2023 Q3 3,694,288 $2,013,385 +$1,372,274 $0.54 29
2023 Q2 1,023,358 $1,616,253 +$1,616,250 $1.58 30